Literature DB >> 2982104

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

M A Muesing, D H Smith, C D Cabradilla, C V Benton, L A Lasky, D J Capon.   

Abstract

The 9,213-nucleotide structure of the AIDS/lymphadenopathy virus has been determined from molecular clones representing the integrated provirus and viral RNA. The sequence reveals that the virus is highly polymorphic and lacks significant nucleotide homology with type C retroviruses characterized previously. Together with an analysis of the two major viral subgenomic RNAs, these studies establish the coding frames for the gag, pol and env genes and predict the expression of a novel gene at the 3' end of the genome unrelated to the X genes of HTLV-1 and -II.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982104     DOI： 10.1038/313450a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  246 in total

1.  Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to bspA.

Authors:  M S Turner; P M Giffard
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

4.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

5.  Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

6.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.

Authors:  M S McGrath; K M Hwang; S E Caldwell; I Gaston; K C Luk; P Wu; V L Ng; S Crowe; J Daniels; J Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.

Authors:  S A Chow; P O Brown
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.